Hvsen Biotechnology Co., Ltd.
SHZ: 300871.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jie Han
- Employees
- 1,068
- Headquarters
- Wuhan, China
- IPO year
- 2020
- Market cap
- CN¥5.2B
- Website
- https://www.whhsyy.com
Loading 300871…
Loading profile data…Frequently asked questions about 300871
What does Hvsen Biotechnology Co., Ltd. (300871.SZ) do?
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin raw materials, various tylvalosin preparations, florfenicol preparations, and other macrolides products. The company produces various veterinary drug products of...
Where does 300871.SZ trade?
Hvsen Biotechnology Co., Ltd. (300871.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300871.SZ in?
Hvsen Biotechnology Co., Ltd. (300871.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hvsen Biotechnology Co., Ltd.?
Jie Han is the chief executive officer of Hvsen Biotechnology Co., Ltd. (300871.SZ).
Where is Hvsen Biotechnology Co., Ltd. headquartered?
Hvsen Biotechnology Co., Ltd. is headquartered in China.
Does 300871.SZ pay a dividend?
Yes — Hvsen Biotechnology Co., Ltd. (300871.SZ) paid a trailing twelve-month dividend of CNY 0.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300871.SZ go public?
Hvsen Biotechnology Co., Ltd. (300871.SZ) completed its initial public offering in 2020.